Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
These schedules are not clinically proven
Injections may be recommended for individuals who have difficulty maintaining healthy B12 levels through diet or oral supplements
Unlock weight loss potential with 5-Amino-1MQ 5-Amino-1MQ is emerging as a game-changer in weight loss and metabolic health
Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
Rotate the site every time, because injecting the same spot repeatedly can cause a fatty lump (lipohypertrophy) that slows absorption, a point the NHS is clear about when it advises you to rotate sites daily
2 Obesity poses a severe threat to overall human health due to its close association with a cluster of pathological entities globally designated as metabolic syndrome, including type 2 diabetes mellitus (T2DM), dyslipidemia, hypertension, and cardiovascular diseases
